Related Experiment Video
Updated: May 7, 2026

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.1K
Research gaps in psoriasis: opportunities for future studies.
Caitriona Ryan1, Neil J Korman2, Joel M Gelfand3
1Psoriasis Research Center, Baylor University Medical Center, Dallas, Texas.
Journal of the American Academy of Dermatology
|October 16, 2013
Summary
Significant research gaps persist in understanding psoriasis pathogenesis and treatment. Future studies should focus on epidemiology, genetics, environmental factors, and comorbidities to improve patient care and develop targeted therapies.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Psoriasis pathogenesis understanding has advanced, leading to targeted therapies.
- Despite progress, significant knowledge gaps remain in psoriasis etiology and management.
- The American Academy of Dermatology identified key research and care deficits.
Purpose of the Study:
- To highlight critical research gaps in psoriasis.
- To propose essential future research directions for psoriasis.
- To inform the development of improved psoriasis treatments and patient care.
Main Methods:
- Review of identified research and care gaps in the American Academy of Dermatology Psoriasis Guidelines of Care.
- Synthesis of existing knowledge and identification of areas requiring further investigation.
- Proposal of specific basic science and clinical research study types.
Main Results:
- Key research areas identified include epidemiology, genetics, environmental triggers, and comorbidities.
- Further molecular studies are needed to understand susceptibility genes and find new therapeutic targets.
- Investigation into the link between psoriasis and cardiometabolic disease is crucial.
Conclusions:
- Addressing identified research gaps is essential for advancing psoriasis understanding and treatment.
- Future research should encompass epidemiology, molecular mechanisms, environmental factors, and comorbidities.
- Identifying biomarkers for disease severity and treatment response will optimize patient therapy.
Keywords:
ACRAmerican College of RheumatologyC-reactive proteinCRPFDAFood and Drug AdministrationIFNILMACEMINBNIHNational Institutes of HealthPsARARCTTNFUVVEGFadjunctive therapiesbiologicscardiovascular diseasecomorbidities in psoriasiscomparative studiesdisease severityenvironmental factors in the development of psoriasisfuture research studiesinterferoninterleukinmajor adverse cardiovascular eventsmethotrexatemolecular studies in psoriatic and psoriatic arthritismyocardial infarctionnarrowbandpathomechanisms and genetics of psoriasisphototherapypsoriasispsoriasis guidelinespsoriasis treatmentpsoriatic arthritispsychologicalrandomized controlled clinical trialresearch gapsrheumatoid arthritistherapeutic targetstopical therapiestumor necrosis factorultravioletvascular endothelial growth factorRelated Concept Videos
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

